TEC-话题@MedSci

#TEC#

484篇内容 | 2719人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1652332, encodeId=10c0165233226, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=罗氏的PD-L1单抗Tecentriq 治疗三阴性乳腺癌即将获得FDA批准, objectType=article, longId=162148, objectId=423a1621482c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=423a1621482c, replyNumber=0, likeNumber=79, createdTime=2020-01-31, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=423a1621482c, moduleTitle=罗氏的PD-L1单抗Tecentriq 治疗三阴性乳腺癌即将获得FDA批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=423a1621482c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652331, encodeId=c7781652331a3, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=J Biomed Nanotechnol：骨髓间充质干细胞和内皮祖细胞共培养增强大段骨缺损修复, objectType=article, longId=162066, objectId=86b0162066a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=86b0162066a6, replyNumber=0, likeNumber=80, createdTime=2020-01-10, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=86b0162066a6, moduleTitle=J Biomed Nanotechnol：骨髓间充质干细胞和内皮祖细胞共培养增强大段骨缺损修复, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=86b0162066a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652362, encodeId=d8641652362a1, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=Artif Cells Nanomed Biotechnol：miR-638或可用于口腔癌的治疗, objectType=article, longId=177530, objectId=74c41e753027, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74c41e753027, replyNumber=0, likeNumber=52, createdTime=2019-12-01, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74c41e753027, moduleTitle=Artif Cells Nanomed Biotechnol：miR-638或可用于口腔癌的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74c41e753027)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652366, encodeId=2232165236613, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=欧盟批准罗氏的PD-L1单抗Tecentriq联合紫杉醇治疗三阴性乳腺癌, objectType=article, longId=178551, objectId=036a1e8551e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=036a1e8551e1, replyNumber=0, likeNumber=0, createdTime=2020-04-05, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=036a1e8551e1, moduleTitle=欧盟批准罗氏的PD-L1单抗Tecentriq联合紫杉醇治疗三阴性乳腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=036a1e8551e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652316, encodeId=b00e1652316de, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=Nature Nanotechnology：DNA检测能够判断抗体的有效性, objectType=article, longId=158297, objectId=3e1c15829e25, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e1c15829e25, replyNumber=0, likeNumber=68, createdTime=2019-07-27, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e1c15829e25, moduleTitle=Nature Nanotechnology：DNA检测能够判断抗体的有效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e1c15829e25)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652390, encodeId=916c165239046, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=阿斯利康携手第一三共开发的trastuzumab deruxtecan研究结果喜人，HER2阳性转移性乳腺癌患者中位无进展生存期达16.4个月 , objectType=article, longId=184672, objectId=90f01846e265, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90f01846e265, replyNumber=0, likeNumber=67, createdTime=2020-04-28, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90f01846e265, moduleTitle=阿斯利康携手第一三共开发的trastuzumab deruxtecan研究结果喜人，HER2阳性转移性乳腺癌患者中位无进展生存期达16.4个月 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=90f01846e265)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652343, encodeId=edc61652343a4, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=抗体-药物偶联物（曲妥珠单抗-deruxtecan）治疗早期乳腺癌, objectType=article, longId=167058, objectId=b1f316e058d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1f316e058d6, replyNumber=0, likeNumber=86, createdTime=2019-08-13, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1f316e058d6, moduleTitle=抗体-药物偶联物（曲妥珠单抗-deruxtecan）治疗早期乳腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b1f316e058d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652322, encodeId=9e031652322ad, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=BMC Biotech：鸡蛋新用途：可提取用于治疗癌症的蛋白质, objectType=article, longId=159749, objectId=361d159e494f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=361d159e494f, replyNumber=0, likeNumber=67, createdTime=2019-06-03, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=361d159e494f, moduleTitle=BMC Biotech：鸡蛋新用途：可提取用于治疗癌症的蛋白质, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=361d159e494f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652321, encodeId=01ac165232105, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=Nanotechnology：电纺PAN纳米纤维的表面功能化与ZnO-Ag异质结构纳米粒子具有优良的抗菌性, objectType=article, longId=159551, objectId=9d10159551f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d10159551f3, replyNumber=0, likeNumber=51, createdTime=2019-10-18, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d10159551f3, moduleTitle=Nanotechnology：电纺PAN纳米纤维的表面功能化与ZnO-Ag异质结构纳米粒子具有优良的抗菌性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d10159551f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652361, encodeId=13d816523617a, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=罗氏PD-L1单抗Tecentriq与化疗药联合治疗膀胱癌III期结果喜人, objectType=article, longId=177126, objectId=a2121e71269e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2121e71269e, replyNumber=0, likeNumber=110, createdTime=2019-10-11, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2121e71269e, moduleTitle=罗氏PD-L1单抗Tecentriq与化疗药联合治疗膀胱癌III期结果喜人, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a2121e71269e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652329, encodeId=7393165232961, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=欧盟监管机构批准罗氏的组合疗法（Tecentriq、阿瓦斯汀和化疗药)用于一线治疗肺癌, objectType=article, longId=161936, objectId=89ae161936ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89ae161936ea, replyNumber=0, likeNumber=0, createdTime=2020-02-03, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89ae161936ea, moduleTitle=欧盟监管机构批准罗氏的组合疗法（Tecentriq、阿瓦斯汀和化疗药)用于一线治疗肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89ae161936ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652340, encodeId=09ad1652340c0, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=J Biomed Nanotechnol：静电纺聚（3-羟基丁酸酯 - 共聚-4-羟基丁酸酯）/聚（乙二醇）纳米纤维膜的成骨潜能, objectType=article, longId=166870, objectId=7bfc1668e009, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7bfc1668e009, replyNumber=0, likeNumber=62, createdTime=2019-09-28, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7bfc1668e009, moduleTitle=J Biomed Nanotechnol：静电纺聚（3-羟基丁酸酯 - 共聚-4-羟基丁酸酯）/聚（乙二醇）纳米纤维膜的成骨潜能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7bfc1668e009)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652337, encodeId=1d77165233e19, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=NICE推荐将罗氏的PD-L1单抗Tecentriq，用于治疗转移性非小细胞肺癌, objectType=article, longId=165339, objectId=4a3216533980, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a3216533980, replyNumber=0, likeNumber=62, createdTime=2019-08-27, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a3216533980, moduleTitle=NICE推荐将罗氏的PD-L1单抗Tecentriq，用于治疗转移性非小细胞肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a3216533980)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652374, encodeId=a29416523e479, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=佐技携微米级精密表面处理技术亮相2019 Medtec 中国展, objectType=article, longId=180348, objectId=b0fb18034876, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0fb18034876, replyNumber=0, likeNumber=78, createdTime=2020-02-03, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0fb18034876, moduleTitle=佐技携微米级精密表面处理技术亮相2019 Medtec 中国展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b0fb18034876)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652345, encodeId=6bf5165234514, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=Artif Cells Nanomed Biotechnol：可降解的聚-L-赖氨酸修饰的PLGA细胞微载体，具有优异的抗菌和成骨活性, objectType=article, longId=168324, objectId=babc168324f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=babc168324f6, replyNumber=0, likeNumber=47, createdTime=2020-02-02, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=babc168324f6, moduleTitle=Artif Cells Nanomed Biotechnol：可降解的聚-L-赖氨酸修饰的PLGA细胞微载体，具有优异的抗菌和成骨活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=babc168324f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652386, encodeId=5bce16523861b, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=Nat Biotechnol：噬菌体：根际菌群的 “作战方案”, objectType=article, longId=184134, objectId=c30f18413440, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c30f18413440, replyNumber=0, likeNumber=76, createdTime=2020-01-31, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c30f18413440, moduleTitle=Nat Biotechnol：噬菌体：根际菌群的 “作战方案”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c30f18413440)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652363, encodeId=a4ef165236353, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=J Nanosci Nanotechnol：改性氧化锆可增强成骨, objectType=article, longId=177558, objectId=f5e31e7558ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5e31e7558ca, replyNumber=0, likeNumber=54, createdTime=2019-12-10, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5e31e7558ca, moduleTitle=J Nanosci Nanotechnol：改性氧化锆可增强成骨, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5e31e7558ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652354, encodeId=1f471652354eb, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=罗氏Genentech将支付10亿美元给日本Sosei Heptares公司，合作开发GPCR药物, objectType=article, longId=175676, objectId=72801e567606, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72801e567606, replyNumber=0, likeNumber=64, createdTime=2020-03-13, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72801e567606, moduleTitle=罗氏Genentech将支付10亿美元给日本Sosei Heptares公司，合作开发GPCR药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72801e567606)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652318, encodeId=250e1652318c0, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=Midatech收到FDA对MTD201临床计划的反馈, objectType=article, longId=159212, objectId=806b1592125e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=806b1592125e, replyNumber=0, likeNumber=70, createdTime=2019-11-19, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=806b1592125e, moduleTitle=Midatech收到FDA对MTD201临床计划的反馈, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=806b1592125e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652356, encodeId=0843165235668, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, objectTitle=J Biomed Nanotechnol：双细胞共培养增强大段骨缺损修复, objectType=article, longId=176392, objectId=43ca1e6392f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43ca1e6392f9, replyNumber=0, likeNumber=0, createdTime=2020-02-29, rootId=0, userName=shock_melon, userId=852f24292001, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43ca1e6392f9, moduleTitle=J Biomed Nanotechnol：双细胞共培养增强大段骨缺损修复, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43ca1e6392f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

TEC

2020-05-29

shock_melon (审核中...)

前往app查看评论内容

#TEC#

罗氏的PD-L1单抗Tecentriq 治疗三阴性乳腺癌即将获得FDA批准

2020-01-31

shock_melon (审核中...)

前往app查看评论内容

#TEC#

J Biomed Nanotechnol：骨髓间充质干细胞和内皮祖细胞共培养增强大段骨缺损修复

2020-01-10

shock_melon (审核中...)

前往app查看评论内容

#TEC#

Artif Cells Nanomed Biotechnol：miR-638或可用于口腔癌的治疗

2019-12-01

shock_melon (审核中...)

前往app查看评论内容

#TEC#

欧盟批准罗氏的PD-L1单抗Tecentriq联合紫杉醇治疗三阴性乳腺癌

2020-04-05

shock_melon (审核中...)

前往app查看评论内容

#TEC#

Nature Nanotechnology：DNA检测能够判断抗体的有效性

2019-07-27

shock_melon (审核中...)

前往app查看评论内容

#TEC#

阿斯利康携手第一三共开发的trastuzumab deruxtecan研究结果喜人，HER2阳性转移性乳腺癌患者中位无进展生存期达16.4个月 

2020-04-28

shock_melon (审核中...)

前往app查看评论内容

#TEC#

抗体-药物偶联物（曲妥珠单抗-deruxtecan）治疗早期乳腺癌

2019-08-13

shock_melon (审核中...)

前往app查看评论内容

#TEC#

BMC Biotech：鸡蛋新用途：可提取用于治疗癌症的蛋白质

2019-06-03

shock_melon (审核中...)

前往app查看评论内容

#TEC#

Nanotechnology：电纺PAN纳米纤维的表面功能化与ZnO-Ag异质结构纳米粒子具有优良的抗菌性

2019-10-18

shock_melon (审核中...)

前往app查看评论内容

#TEC#

罗氏PD-L1单抗Tecentriq与化疗药联合治疗膀胱癌III期结果喜人

2019-10-11

shock_melon (审核中...)

前往app查看评论内容

#TEC#

欧盟监管机构批准罗氏的组合疗法（Tecentriq、阿瓦斯汀和化疗药)用于一线治疗肺癌

2020-02-03

shock_melon (审核中...)

前往app查看评论内容

#TEC#

J Biomed Nanotechnol：静电纺聚（3-羟基丁酸酯 - 共聚-4-羟基丁酸酯）/聚（乙二醇）纳米纤维膜的成骨潜能

2019-09-28

shock_melon (审核中...)

前往app查看评论内容

#TEC#

NICE推荐将罗氏的PD-L1单抗Tecentriq，用于治疗转移性非小细胞肺癌

2019-08-27

shock_melon (审核中...)

前往app查看评论内容

#TEC#

佐技携微米级精密表面处理技术亮相2019 Medtec 中国展

2020-02-03

shock_melon (审核中...)

前往app查看评论内容

#TEC#

Artif Cells Nanomed Biotechnol：可降解的聚-L-赖氨酸修饰的PLGA细胞微载体，具有优异的抗菌和成骨活性

2020-02-02

shock_melon (审核中...)

前往app查看评论内容

#TEC#

Nat Biotechnol：噬菌体：根际菌群的 “作战方案”

2020-01-31

shock_melon (审核中...)

前往app查看评论内容

#TEC#

J Nanosci Nanotechnol：改性氧化锆可增强成骨

2019-12-10

shock_melon (审核中...)

前往app查看评论内容

#TEC#

罗氏Genentech将支付10亿美元给日本Sosei Heptares公司，合作开发GPCR药物

2020-03-13

shock_melon (审核中...)

前往app查看评论内容

#TEC#

Midatech收到FDA对MTD201临床计划的反馈

2019-11-19

shock_melon (审核中...)

前往app查看评论内容

#TEC#

J Biomed Nanotechnol：双细胞共培养增强大段骨缺损修复

2020-02-29

科室
- - 订阅+
  - 更多科室
工具
服务